Recent advances in hydrogels for preventing tumor recurrence

Biomater Sci. 2023 Apr 11;11(8):2678-2692. doi: 10.1039/d3bm00003f.

Abstract

Malignant tumors remain a high-risk disease with high mortality all over the world. Among all the cancer treatments, surgery is the primary approach in the clinical treatment of tumors. However, tumor invasion and metastasis pose challenges for complete tumor resection, accompanied by high recurrence rates and reduced quality of life. Hence, there is an urgent need to explore effective adjuvant therapies to prevent postoperative tumor recurrence and relieve the pain of the patients. Nowadays, the booming local drug delivery systems which can be applied as postoperative adjuvant therapies have aroused people's attention, along with the rapid development in the pharmaceutical and biological materials fields. Hydrogels are a kind of unique carrier with prominent biocompatibility among a variety of biomaterials. Due to their high similarity to human tissues, hydrogels which load drugs/growth factors can prevent rejection reactions and promote wound healing. In addition, hydrogels are able to cover the postoperative site and maintain sustained drug release for the prevention of tumor recurrence. In this review, we survey controlled drug delivery hydrogels such as implantable, injectable and sprayable formulations and summarize the properties required for hydrogels used as postoperative adjuvant therapies. The opportunities and challenges in the design and clinical application of these hydrogels are also elaborated.

Publication types

  • Review

MeSH terms

  • Biocompatible Materials / therapeutic use
  • Drug Delivery Systems
  • Humans
  • Hydrogels* / therapeutic use
  • Neoplasm Recurrence, Local* / drug therapy
  • Quality of Life

Substances

  • Hydrogels
  • Biocompatible Materials